Representative Matters

Advanced policy research and assessment for the Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone and the development of Shenzhen's plans and supporting policies for strategic emerging and future industries, with responsibility for drafting and reviewing policy documents and coordinating government departments.

Coordinated the implementation in Shenzhen of major projects involving CSOT, SMIC, Hengli and the China National GeneBank, undertaking policy assessment, interdepartmental coordination, and policy and legal work during implementation.

Participated in a UK semiconductor company's investment project in China, with responsibility for policy analysis, compliance assessment and project implementation coordination.

Participated in bringing a Singapore semiconductor testing company to Shenzhen to establish a manufacturing base and coordinated project implementation.

Advanced a Hong Kong financing transaction for a leading Chinese AI company on behalf of an investor, with responsibility for due diligence, transaction structuring and investment execution.

Advanced the establishment of the fund's Hong Kong platform, with responsibility for cross-border investment structuring and regulatory compliance analysis, offshore fund formation, outbound transfers of mainland capital and arrangements for the Hong Kong platform's investment operations.

Advised on the use of onshore capital for investment in an RMB International Investment and Loan Fund and on related PRC outbound-investment compliance.

Advised on the formation of an offshore US dollar-denominated fund, including fund structuring and drafting the principal fund documents.

Advised a state-owned venture capital enterprise on the formation of an industrial M&A fund and conducted due diligence on a leading private equity manager.

Conducted a legal review of a proposed cooperation arrangement between a Shenzhen district-level industry guidance fund and an offshore fund manager.

Issued legal opinions for a state-owned venture capital enterprise in connection with a sci-tech innovation corporate bond offering on the Shenzhen Stock Exchange.

Advised a leading Chinese pharmaceutical company on the acquisition of European rare-disease pipeline assets, including transaction structuring, due diligence and cross-border execution.

Assessed US export-control exposure for an investment by a Shenzhen institution and advised on material regulatory risks and mitigation measures.

Advised an LCD panel manufacturer throughout the establishment of a manufacturing operation in Vietnam, including investment structuring, entity establishment and operational compliance.

Advised a wear-resistant materials company on the development of a manufacturing operation in Malaysia, including investment structuring, local compliance and implementation.

Coordinated legal advice for an aged-care and healthcare group on an investment in Australia.

Advised a Hong Kong-listed biopharmaceutical company on an investment in a mainland China biopharmaceutical project, including transaction and implementation matters.

Advised on a transaction with an Israeli healthcare fund, including structuring, due diligence and compliance analysis.

Issued legal opinions for an Anhui provincial state-owned enterprise in connection with the disposal of an offshore real estate project.

Coordinated cross-border legal advice for a Shandong company following an investment fraud incident in Kazakhstan.

Advised a state-owned advanced-materials company on issues arising from a debtor's entry into Russian bankruptcy proceedings.

Advised on the recognition and enforcement of a CIETAC arbitral award in the United States.